Gordon Kuntz
Oncology pathways and market access strategist
kuntzconsulting
Minnesota, United States
Joined April 2026
Summary
Veteran oncology pathways strategist who connects clinical, payer, and commercial perspectives to help organizations implement and sustain clinical pathways. gordonkuntz+1
Advocate for clinician-centered pathway design, emphasizing treatment efficacy and toxicity considerations ahead of cost as the primary decision drivers. onclive
Producer, host, and public speaker who educates stakeholders through podcasts, conference moderation, and editorial work to advance pathway transparency and value-based oncology models. hmpgloballearningnetwork+1
Brings hands-on program and research experience in payer-facing oncology initiatives, including oncology medical home demonstrations that measured clinical adherence and utilization outcomes. nih+1
Work
Education
Projects
Writing
Michigan Oncology Medical Home Demonstration Project: first-year results
January 1, 2014Report of the Michigan Oncology Medical Home Demonstration Project (year 1) describing implementation of an oncology medical home across community practices, demonstrating reductions in ER visits and hospitalizations, adherence to guidelines, and estimated cost savings.
What Do We Mean When We Talk About 'Clinical Pathways'?
Article explaining clinical pathways: the jargon, development process, and implications for practices and health systems, aimed at clarifying pathway concepts for those new to the field.